290 related articles for article (PubMed ID: 18406872)
41. Interstitial insertion of varying amounts of ABL-containing genetic material into chromosome 22 in Ph-negative CML.
Rassool F; Martiat P; Taj A; Klisak I; Goldman J
Leukemia; 1990 Apr; 4(4):273-7. PubMed ID: 2164119
[TBL] [Abstract][Full Text] [Related]
42. [The application of fluorescence in situ hybridization in detecting chronic myeloid leukemia].
Qiu HR; Miao KR; Wang R; Qiao C; Zhang JF; Zhang SJ; Qian SX; Xu W; Li JY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):207-10. PubMed ID: 19350518
[TBL] [Abstract][Full Text] [Related]
43. [Variant Philadelphia chromosome identified by interphase fluorescence in situ hybridization (FISH) without evidence on G-banded karyotyping and metaphase FISH].
Kim MK; Mun YC; Seong CM; Chung WS; Huh J
Korean J Lab Med; 2010 Dec; 30(6):711-7. PubMed ID: 21157160
[TBL] [Abstract][Full Text] [Related]
44. Location of the BCR-ABL fusion gene on the 9q34 band in two cases of Ph-positive chronic myeloid leukemia.
Aurich J; Dastugue N; Duchayne E; Schlaifer D; Rigal-Huguet F; Caballin MR
Genes Chromosomes Cancer; 1997 Oct; 20(2):148-54. PubMed ID: 9331565
[TBL] [Abstract][Full Text] [Related]
45. Novel variant Ph translocation t(9;22;11)(q34;q11.2;p15)inv(9)(p13q34) in chronic myeloid leukemia involving a one-step mechanism.
Belli C; Alú MF; Alfonso G; Bianchini M; Larripa I
Cytogenet Genome Res; 2011; 132(4):304-8. PubMed ID: 21212648
[TBL] [Abstract][Full Text] [Related]
46. A dual colour dual fusion fluorescence in situ hybridisation study on the genesis of complex variant translocations in chronic myelogenous leukaemia.
So CC; Wan TS; Yip SF; Chan LC
Oncol Rep; 2008 May; 19(5):1181-4. PubMed ID: 18425374
[TBL] [Abstract][Full Text] [Related]
47. A complex translocation t(5;9;22) in Philadelphia cells involving the short arm of chromosome 5 in a case of chronic myelogenous leukemia.
Al-Achkar W; Wafa A; Nweder MS
J Exp Clin Cancer Res; 2007 Sep; 26(3):411-5. PubMed ID: 17987804
[TBL] [Abstract][Full Text] [Related]
48. Novel complex t(V;9;22) rearrangements in three cases with chronic myeloid leukemia and a rare translocation in a case with classical Philadelphia chromosome.
Mkrtchyan H; Ghazaryan S; Avetisyan G; Hovhannisyan A; Muradyan L; Daghbashyan S; Karst C; Gross M; Hinreiner S; Aroutiounian R; Liehr T
Oncol Rep; 2008 Jul; 20(1):99-104. PubMed ID: 18575724
[TBL] [Abstract][Full Text] [Related]
49. Fluorescence in situ hybridization dissection of a chronic myeloid leukemia case bearing the apparently balanced translocations (9;22)(q34;q11.2) and (11;11)(p15;q13).
Malvestiti F; Colombo D; Perego D; Rodeschini O; Finelli P; Larizza L; Giardino D
Cancer Genet Cytogenet; 2009 Jan; 188(1):42-7. PubMed ID: 19061779
[TBL] [Abstract][Full Text] [Related]
50. Prognostic Implications of Derivative Chromosome 9 Deletions in Patients with Advanced-Stage Chronic Myelogenous Leukemia.
Chandran RK; Geetha N; Sakthivel KM; Aswathy CG; Gopinath P; Nair JKKM; Sreedharan H
J Environ Pathol Toxicol Oncol; 2018; 37(2):117-126. PubMed ID: 30055547
[TBL] [Abstract][Full Text] [Related]
51. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P
Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300
[TBL] [Abstract][Full Text] [Related]
52. Molecular cytogenetic characterization of Philadelphia-negative rearrangements in chronic myeloid leukemia patients.
Bennour A; Bellâaj H; Ben Youssef Y; Elloumi M; Khelif A; Saad A; Sennana H
J Cancer Res Clin Oncol; 2011 Sep; 137(9):1329-36. PubMed ID: 21739181
[TBL] [Abstract][Full Text] [Related]
53. [Fluorescent in-situ hybridization technique (FISH) in the diagnosis of Philadelphia translocation in chronic myeloid leukemia].
Martinet D; Mühlematter D; Jotterand Bellomo M
Schweiz Med Wochenschr; 1996 May; 126(20):855-63. PubMed ID: 8685681
[TBL] [Abstract][Full Text] [Related]
54. Clinical evaluation of a DNA probe assay for the Philadelphia (Ph1) translocation in chronic myelogenous leukemia.
Blennerhassett GT; Furth ME; Anderson A; Burns JP; Chaganti RS; Blick M; Talpaz M; Dev VG; Chan LC; Wiedemann LM
Leukemia; 1988 Oct; 2(10):648-57. PubMed ID: 3050293
[TBL] [Abstract][Full Text] [Related]
55. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis.
Kolomietz E; Al-Maghrabi J; Brennan S; Karaskova J; Minkin S; Lipton J; Squire JA
Blood; 2001 Jun; 97(11):3581-8. PubMed ID: 11369654
[TBL] [Abstract][Full Text] [Related]
56. Initial diagnosis of chronic myelogenous leukemia based on quantification of M-BCR status using droplet digital PCR.
Lund HL; Hughesman CB; McNeil K; Clemens S; Hocken K; Pettersson R; Karsan A; Foster LJ; Haynes C
Anal Bioanal Chem; 2016 Feb; 408(4):1079-94. PubMed ID: 26631023
[TBL] [Abstract][Full Text] [Related]
57. Molecular biology of the Philadelphia positive leukaemias.
Morgan GJ; Wiedemann LM
Recenti Prog Med; 1989 Oct; 80(10):508-19. PubMed ID: 2690217
[TBL] [Abstract][Full Text] [Related]
58. Philadelphia chromosome-positive chronic myelogenous leukemia with deleted fusion of BCR and ABL genes.
Ohyashiki K; Ohyashiki JH; Iwabuchi H; Tauchi T; Iwabuchi A; Toyama K
Jpn J Cancer Res; 1990 Jan; 81(1):35-42. PubMed ID: 2157692
[TBL] [Abstract][Full Text] [Related]
59. A complex three-way translocation with deletion of the TP53 gene in a blast crisis chronic myeloid leukemia patient.
Kokate P; Dalvi R; Mandava S
J Cancer Res Ther; 2015; 11(4):1037. PubMed ID: 26881646
[TBL] [Abstract][Full Text] [Related]
60. High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemia.
Xie J; Wang Q; Wang Q; Yao H; Wen L; Ma L; Wu D; Chen S
Cancer Genet; 2014 May; 207(5):226-30. PubMed ID: 24998463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
